These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 30883340)
1. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance. Sahami-Fard MH; Kheirandish S; Sheikhha MH Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340 [TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
3. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
4. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer. Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615 [TBL] [Abstract][Full Text] [Related]
5. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations. Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896 [TBL] [Abstract][Full Text] [Related]
6. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer. Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052 [TBL] [Abstract][Full Text] [Related]
8. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer. Li L; Wang A; Cai M; Tong M; Chen F; Huang L Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801 [TBL] [Abstract][Full Text] [Related]
9. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer. Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735 [TBL] [Abstract][Full Text] [Related]
10. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer. Bilegsaikhan E; Liu HN; Shen XZ; Liu TT J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077 [TBL] [Abstract][Full Text] [Related]
11. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
12. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer. Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108 [TBL] [Abstract][Full Text] [Related]
15. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793 [TBL] [Abstract][Full Text] [Related]
16. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223 [TBL] [Abstract][Full Text] [Related]
17. Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection. Huang G; Wei B; Chen Z; Wang J; Zhao L; Peng X; Liu K; Lai Y; Ni L Biomark Med; 2020 Jun; 14(9):749-760. PubMed ID: 32672054 [No Abstract] [Full Text] [Related]
18. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer. Ghanbari R; Mosakhani N; Asadi J; Nouraee N; Mowla SJ; Poustchi H; Malekzadeh R; Knuutila S Cancer Biomark; 2015; 15(2):189-95. PubMed ID: 25519020 [TBL] [Abstract][Full Text] [Related]
19. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Yuan D; Li K; Zhu K; Yan R; Dang C Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion. Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]